MDPI and ACS Style
Mandić, D.; Nežić, L.; Amdžić, L.; Vojinović, N.; Gajanin, R.; Popović, M.; Đeri, J.; Balint, M.T.; Dumanović, J.; Milovanović, Z.;
et al. Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment. Cancers 2023, 15, 4106.
https://doi.org/10.3390/cancers15164106
AMA Style
Mandić D, Nežić L, Amdžić L, Vojinović N, Gajanin R, Popović M, Đeri J, Balint MT, Dumanović J, Milovanović Z,
et al. Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment. Cancers. 2023; 15(16):4106.
https://doi.org/10.3390/cancers15164106
Chicago/Turabian Style
Mandić, Danijela, Lana Nežić, Ljiljana Amdžić, Nataša Vojinović, Radoslav Gajanin, Miroslav Popović, Jugoslav Đeri, Milena Todorović Balint, Jelena Dumanović, Zoran Milovanović,
and et al. 2023. "Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment" Cancers 15, no. 16: 4106.
https://doi.org/10.3390/cancers15164106